People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus for certain participants in recent trials in Africa and Europe ...
Stacker on MSN
Achieving lasting remission for HIV
Knowable Magazine reports on breakthroughs in HIV treatment; engineered antibodies show promise for long-term control, ...
Long Island Press on MSN
The breakthrough drug transforming HIV prevention: FDA-approved lenacapavir protects with twice-yearly injections
The U.S. Food and Drug Administration (FDA) recently approved a groundbreaking new option for preventing HIV, the virus that ...
Today, we confront emerging threats from a range of respiratory viruses, insect-transmitted viruses, and viruses we have not ...
A landmark breakthrough in HIV prevention received final approval from the Food and Drug Administration last month. Gilead Sciences’ lenacapavir is so effective that global health leaders had started ...
Investigational Treatment Regimen Could Expand Options for Virologically Suppressed Adults –– Positive Phase 3 Results from ...
Two early trials found that engineered antibodies can lead to long-term HIV remission without ongoing treatment — not a full ...
The Noguchi Memorial Institute for Medical Research (NMIMR) has developed what scientists describe as “a ground-breaking ...
A drug with the potential to drastically curb the HIV epidemic just cleared its first regulatory hurdle. On Wednesday, the Food and Drug Administration approved lenacapavir for the prevention of HIV.
The Noguchi Memorial Institute for Medical Research (NMIMR) has developed what scientists are calling a potential ...
A landmark breakthrough in HIV prevention — a scientific feat decades in the making — received final approval from the Food and Drug Administration last month. Gilead Sciences’ lenacapavir is so ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback